Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Sales | 497,528 | 476,487 | 413,787 | 275,189 | 334,647 |
| Cost of Goods | 304,120 | 276,382 | 235,492 | 130,594 | 92,106 |
| Gross Profit | 193,408 | 200,105 | 178,295 | 144,595 | 242,541 |
| Operating Expenses | 170,248 | 125,932 | 359,849 | 81,635 | 69,096 |
| Operating Income | 23,280 | 74,555 | -181,062 | 63,554 | 173,551 |
| Interest Expense | 42,880 | 43,018 | 36,622 | 21,051 | 20,891 |
| Other Income | 4,794 | -8,963 | -44,822 | 9,513 | 20,209 |
| Pre-tax Income | -14,806 | 22,574 | -262,506 | 52,016 | 172,869 |
| Income Tax | 5,524 | 5,109 | -12,416 | 364 | -30,017 |
| Net Income Continuous | -20,330 | 17,465 | -250,090 | 51,652 | 202,886 |
| Minority Interests | -63,097 | 10,513 | -30,645 | 51,652 | 1,033 |
| Net Income | $42,767 | $6,952 | $-219,445 | $N/A | $201,853 |
| EPS Basic Total Ops | -0.06 | 0.05 | -0.15 | N/A | N/A |
| EPS Basic Continuous Ops | 0.25 | 0.14 | -1.97 | N/A | N/A |
| EPS Diluted Total Ops | -0.06 | 0.05 | -0.15 | N/A | N/A |
| EPS Diluted Continuous Ops | 0.25 | 0.14 | -1.97 | N/A | N/A |
| EBITDA(a) | $82,835 | $119,211 | $-147,509 | $79,475 | $187,083 |